Cargando…

Updated Austrian treatment algorithm in HER2+ metastatic breast cancer

A group of Austrian breast cancer specialists met in December 2020 to establish a comprehensive clinical benefit-risk profile of available HER2-targeted therapies based on recent data and to develop an updated treatment algorithm by consensus over several months in 2021. A total of four scenarios we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartsch, Rupert, Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Petru, Edgar, Egle, Daniel, Petzer, Andreas, Balic, Marija, Pluschnig, Ursula, Sliwa, Thamer, Singer, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Consensus Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813714/ https://www.ncbi.nlm.nih.gov/pubmed/35089396 http://dx.doi.org/10.1007/s00508-021-01987-9

Ejemplares similares

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update
por: Rinnerthaler, Gabriel, et al.
Publicado: (2022)

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
por: Gampenrieder, Simon Peter, et al.
Publicado: (2021)

Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6)
por: Rinnerthaler, Gabriel, et al.
Publicado: (2021)

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018)

Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
por: Fiegl, Michael, et al.
Publicado: (2011)

Indications for liver transplantation in adults: Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)
por: Graziadei, Ivo, et al.
Publicado: (2016)

Treatment Landscape for Patients with HER2-Positive Metastatic Breast Cancer: A Review on Emerging Treatment Options
por: Gampenrieder, Simon Peter, et al.
Publicado: (2020)

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
por: Mandorfer, Mattias, et al.
Publicado: (2023)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

Management of malignant pleural mesothelioma—part 2: therapeutic approaches: Consensus of the Austrian Mesothelioma Interest Group (AMIG)
por: Hoda, Mir Alireza, et al.
Publicado: (2016)

Expert consensus on maintenance treatment for metastatic colorectal cancer in China
por: Xu, Rui-Hua, et al.
Publicado: (2016)

International consensus on radiotherapy in metastatic non-small cell lung cancer
por: Zhu, Zhengfei, et al.
Publicado: (2022)

Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging: Consensus of the Austrian Mesothelioma Interest Group (AMIG)
por: Geltner, Christian, et al.
Publicado: (2016)

Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions
por: Tamandl, Dietmar, et al.
Publicado: (2018)

Immunosuppressives and biologics during pregnancy and lactation: A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation
por: Puchner, Antonia, et al.
Publicado: (2019)

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
por: Bartsch, Rupert
Publicado: (2021)

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update
por: Toplak, Hermann, et al.
Publicado: (2016)

Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
por: Kutschera, Maximilian, et al.
Publicado: (2022)

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2019)

Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2009)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

ASCO 2018 highlights: metastatic breast cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018)

SABCS 2016: systemic therapy for metastatic breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)
por: Rath, Eva, et al.
Publicado: (2022)

Cure in metastatic breast cancer
por: Westphal, Theresa, et al.
Publicado: (2018)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT
por: Magnes, Teresa, et al.
Publicado: (2021)

Extravasation emergencies: state-of-the-art management and progress in clinical research
por: Pluschnig, Ursula, et al.
Publicado: (2016)

Updated ACVIM consensus statement on leptospirosis in dogs
por: Sykes, Jane E., et al.
Publicado: (2023)

ACVIM consensus update on Lyme borreliosis in dogs and cats
por: Littman, Meryl P., et al.
Publicado: (2018)

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update
por: Mackenzie, Ian R. A., et al.
Publicado: (2009)

An update on gestational hyperglycemia diagnosis during the COVID-19 pandemic()
por: Codina, Mercè, et al.
Publicado: (2020)

Updated approach for the management of osteoporosis in Turkey: a consensus report
por: Kirazlı, Yeşim, et al.
Publicado: (2020)

A framework for the development of effective anti-metastatic agents
por: Anderson, Robin L., et al.
Publicado: (2018)

Update on Canine and Feline Blood Donor Screening for Blood‐Borne Pathogens
por: Wardrop, K.J., et al.
Publicado: (2016)

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
por: Sweet, David G., et al.
Publicado: (2023)

Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

Diagnosis and management of osteoporosis in Saudi Arabia: 2023 key updates from the Saudi Osteoporosis Society
por: Al-Saleh, Yousef, et al.
Publicado: (2023)

Insulin for type 2 diabetes: choosing a second-line insulin regimen
por: Barnett, A, et al.
Publicado: (2008)

Is adiposopathy (sick fat) an endocrine disease?
por: Bays, H E, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6f5di4hai91tiq1853kf9lhub8